In her debut blog, Lilli Waples summarises a recent Cochrane Review on the effectiveness of psychosocial interventions to reduce parental substance use.[read the full story...]
Women-only drug treatment services: their time has come #DAWF18
Emma Wincup and Katharine Sacks-Jones explore the findings of a recent qualitative study that asks: Do women with complex alcohol and other drug use histories want women-only residential treatment?[read the full story...]
WHO cares? Treatment coverage for substance use disorders: results from 26 countries
Ian Hamilton reports on an analysis of data from the World Mental Health Surveys, which estimates treatment coverage for people with substance use disorders.[read the full story...]
Women in prison have significantly more drug problems than men #WomenAndDrugs
Geoff Page publishes his debut elf blog on a new systematic review of alcohol and drug use disorders in recently incarcerated men and women.
We’re publishing this blog to coincide with the #WomenAndDrugs event taking place in York today, which you can follow on Twitter and via our live podcast.[read the full story...]
NICE one? Is NHS guidance on substance misuse fit for purpose?
Ian Hamilton explains why the National Institute for Health and Care Excellence have missed a trick by not updating their 2007 guidance on psychosocial interventions for substance misuse.[read the full story...]
New Dental Prescribing App launched
The Scottish Dental Clinical Effectiveness Programme (SDCEP) has launched an app for use on iPhone®, iPad® and iPod touch® based on the second edition of their Drug Prescribing for Dentistry guidance. The app aims to facilitate drug prescribing within primary care dental practice by providing mobile access to the latest dentally relevant information compiled from [read the full story…]
Little evidence for drug treatments for oral submucous fibrosis
Oral Submucous fibrosis (OSMF) is a chronic disease caused by the use of areca nut. It is associated with significant morbidity (including pain and reduced oral opening) and an increased risk for malignancy. The aim of this review identify the published literature on the role of various drugs in the treatment of oral submucous fibrosis. [read the full story…]